NCT00040053已完成2 期
Double-Blind, Placebo-Controlled, Dose Response Trial of Ondansetron for the Treatment of Methamphetamine Dependence.
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 154
- 试验地点
- 12
- 主要终点
- Clinicial improvement
研究概览
简要总结
The purpose of this study is to assess ondansetron for the treatment of methamphetamine dependence.
详细描述
This study was designed to be a preliminary assessment of the efficacy and safety of 3-wide range doses of ondansetron (0.25, 1.0 and 4.0 mg taken orally twice per day) to reduce methamphetamine use in subjects with methamphetamine dependence and to determine the optimal dose of ondansetron.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 99 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age. Treatment seeking for meth dependence.
排除标准
- •Please contact site director for more details.
结局指标
主要结局
Clinicial improvement
次要结局
未报告次要终点
研究者
研究点 (12)
Loading locations...
相似试验
已完成
2 期
Pharmacogenetic Study of Ondansetron in Alcohol Use DisorderAlcohol Use DisorderNCT02354703University of Maryland, Baltimore293
已完成
2 期
Ondansetron for the Treatment of Cocaine Dependence - 1Cocaine-Related DisordersDrug Administration ScheduleNCT00033085National Institute on Drug Abuse (NIDA)60
终止
2 期
Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive DisorderObsessive-compulsive DisorderNCT01275248Transcept Pharmaceuticals130
已完成
4 期
Ondansetron's Opposite Effect on Postoperative Analgesia of AcetaminophenPostoperative PainNCT02296333Mustafa Kemal University80
已完成
3 期
Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in SchizophreniaSchizoaffective and Schizophreniform DisordersSchizophreniaNCT01121042Bayside Health85